Defining proteostasis networks in axon segments
定义轴突段中的蛋白质稳态网络
基本信息
- 批准号:10626162
- 负责人:
- 金额:$ 37.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:3&apos Untranslated RegionsAddressAffectAgeAgingAlzheimer&aposs DiseaseAnabolismAttentionAxonBiologyBrainCell DeathCellsClinicalConsumptionCytoplasmDefectDegradation PathwayDiseaseEnvironmentEnzymesEventFailureGoalsGrowthHealthHippocampusHumanHuman bodyInjuryKnowledgeLengthMaintenanceMessenger RNAMetabolismMolecular ChaperonesMolecular ConformationNerve DegenerationNervous SystemNeurodegenerative DisordersNeuronsNiacinamideOutcomeParkinson DiseasePathway interactionsPeripheral Nervous System DiseasesPredispositionProcessProtein BiosynthesisProteinsProteomeQuality of lifeReagentRibosomesRoleSliceSynapsesTherapeuticTranscriptTranslationsWorkaging brainaxon injuryaxon regenerationaxonal degenerationcancer cellcytotoxicimprovedinsightmetermisfolded proteinneural circuitneuron lossneuronal cell bodyneuronal circuitryneuroprotectionnon-Nativepolypeptidepreservationprotein aggregationprotein degradationprotein foldingprotein misfoldingproteostasisproteotoxicityresilienceresponse to injurystressorsynaptic function
项目摘要
PROJECT SUMMARY/ABSTRACT
Neurodegenerative disorders represent a significant challenge to human health. Many therapeutic strategies
revolve around suppressing death of the neuronal cell body. However, neuronal connectivity depends on long
projections called axons that use specialized mechanisms to survive in isolation from the soma. The
degeneration of axons is a common, sometimes initiating event in a variety of neurodegenerative disorders
including Alzheimer’s disease, Parkinson’s disease, and peripheral neuropathies. Protecting axon health is
necessary for sustaining functional connectivity and will have broad relevance to many diseases. In the aging
nervous system there is a well-documented decline in protein homeostasis and accumulation of protein
aggregates that threaten neuronal function. Protein homeostasis is predominantly studied in context of the
neuronal cell body. However, axons are also susceptible because protein aggregates interfere with transport
and disrupt synaptic function. Polypeptides are most vulnerable to misfolding and aggregation as they exit the
ribosome. Axons locally synthesize many proteins needed for survival however there is a gap in knowledge
regarding basic mechanisms that protect axons from protein misfolding. This project will determine the capacity
of axon segments to resist protein misfolding and aggregation. We will also determine the preferred
mechanisms used within axon segments for degrading non-native polypeptides and disposing of aggregates.
NAD+ levels decline as we age and this project will identify the consequences local NAD+ depletion on protein
homeostasis within the axon compartment. Altogether, this project will generate new insight on local
mechanisms controlling axon health and reveal treatment opportunities in neurodegenerative disorders.
项目概要/摘要
神经退行性疾病对人类健康提出了重大挑战。
围绕抑制神经细胞体的死亡然而,神经连接依赖于长期。
称为轴突的投影使用专门的机制在与躯体隔离的情况下生存。
轴突变性是多种神经退行性疾病中的常见现象,有时甚至是始发事件
包括阿尔茨海默病、帕金森病和周围神经病,保护轴突健康是。
维持功能连接所必需的,并且与衰老过程中的许多疾病具有广泛的相关性。
神经系统中,蛋白质稳态和蛋白质积累均出现下降
威胁神经功能的聚集体主要是在以下背景下研究的。
然而,轴突也很容易受到影响,因为蛋白质聚集物会干扰运输。
并破坏突触功能。当多肽退出时,它们最容易发生错误折叠和聚集。
核糖体局部合成许多生存所需的蛋白质,但知识存在空白。
关于保护轴突免受蛋白质错误折叠的基本机制,该项目将确定其能力。
我们还将确定首选的轴突片段以抵抗蛋白质错误折叠和聚集。
轴突片段内用于降解非天然多肽和处置聚集体的机制。
NAD+ 水平随着年龄的增长而下降,该项目将确定局部 NAD+ 消耗对蛋白质的影响
总而言之,该项目将产生关于局部的新见解。
控制轴突健康的机制并揭示神经退行性疾病的治疗机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Summers其他文献
Daniel Summers的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Summers', 18)}}的其他基金
Identifying mechanisms that regulate local axon vulnerability to pathological degeneration
识别调节局部轴突易受病理变性影响的机制
- 批准号:
10415770 - 财政年份:2022
- 资助金额:
$ 37.34万 - 项目类别:
Defining proteostasis networks in axon segments
定义轴突段中的蛋白质稳态网络
- 批准号:
10493637 - 财政年份:2022
- 资助金额:
$ 37.34万 - 项目类别:
Identifying mechanisms that regulate local axon vulnerability to pathological degeneration
识别调节局部轴突易受病理变性影响的机制
- 批准号:
10563209 - 财政年份:2022
- 资助金额:
$ 37.34万 - 项目类别:
相似海外基金
CRISPR-Cas Editing as a Genetic Cure for Autosomal Dominant Polycystic Kidney Disease
CRISPR-Cas 编辑作为常染色体显性多囊肾病的基因治疗
- 批准号:
10822502 - 财政年份:2023
- 资助金额:
$ 37.34万 - 项目类别:
SELENOF is a Novel Tumor Suppressor and a New Target to Overcome Racial Disparity in Breast Cancer.
SELENOF 是一种新型肿瘤抑制剂,也是克服乳腺癌种族差异的新靶点。
- 批准号:
10735662 - 财政年份:2023
- 资助金额:
$ 37.34万 - 项目类别:
Restriction of KSHV by cellular RNA decay pathways
细胞 RNA 衰变途径对 KSHV 的限制
- 批准号:
10699800 - 财政年份:2023
- 资助金额:
$ 37.34万 - 项目类别:
HMGA2 mediates resistance to therapy in prostate cancer
HMGA2 介导前列腺癌治疗耐药
- 批准号:
10622747 - 财政年份:2023
- 资助金额:
$ 37.34万 - 项目类别:
The Role of mRNA Degradation in Embryonic Cell Fate Specification
mRNA 降解在胚胎细胞命运规范中的作用
- 批准号:
10604512 - 财政年份:2023
- 资助金额:
$ 37.34万 - 项目类别: